🇬🇷

Greece for Biotech / Life Sciences

europeWorldwideBIOTECH / LIFE SCIENCES
70
Overall
61
BIOTECH
Industry Rank
#11of 27
Key Strength
Funding
Tax Regime
Worldwide
Verdict
Best For

Founders seeking capital - Greece's funding access (85/100) suits startups that need VC relationships and government co-investment programs.

Not Ideal For

Founders focused on personal income tax efficiency - Greece's personal tax score (45/100) is not a primary advantage.

Bottom Line

Ranked #11 of 27 jurisdictions for Biotech / Life Sciences. Greece's Biotech / Life Sciences score of 61/100 is close to its overall score of 70/100, indicating balanced performance across dimensions.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Funding85

Strong funding environment for biotech / life sciences operators.

Visa85

Strong visa environment for biotech / life sciences operators.

Family85

Strong family environment for biotech / life sciences operators.

Watch Outs
Tax Res.45

Lower tax res. score - verify current requirements carefully.

Tax52

Lower tax score - verify current requirements carefully.

Residency60

Lower residency score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
22%
Corporate Tax
16
Active VCs
$600M
VC Deployed
Yes
Gov Grants
Yes
EU Funding
68
Talent Pool
Yes
IP Box Regime
10
Incorporation

Why Greece Works for Biotech / Life Sciences

Funding access (85/100) is a standout for Greece Biotech / Life Sciences companies. The local market has 16 active VC funds, with average seed checks of $500K. Government grant programs include Research - Innovate 2021-2027 (ESPA/NSRF) ($325K) and ESPA Support for New SME Establishment ($440K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Family viability (85/100) is a genuine strength for Greece - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 40 (NYC = 100), with a comfortable family monthly budget of $4K. Safety scores 54/100. International schools are available, and healthcare quality scores 59/100 with private insurance running approximately $540/month.

Operational ease (83/100) makes Greece practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 10 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Watch Outs for Biotech / Life Sciences Founders in Greece

Personal tax (45/100): Personal income tax tops out at 44%, which is above-average for founder-friendly jurisdictions. The worldwide taxation system means all global income is taxable for residents. Founders planning high personal distributions should model after-tax take-home carefully against lower-tax alternatives.

Corporate tax (52/100): Tax efficiency is not the primary reason to choose Greece for Biotech / Life Sciences operations. Founders whose primary goal is minimising the corporate tax line should model effective rates carefully and compare against jurisdictions with zero or near-zero corporate tax.

Residency access (60/100): Visa and residency options for non-citizens are more limited or complex than in purpose-built founder-friendly jurisdictions. Founders who need a fast, reliable residency pathway should verify program eligibility requirements before choosing Greece as a base.

Setup Requirements for Biotech / Life Sciences in Greece
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: moderate access for foreign founders. Common options include Alpha Bank, National Bank of Greece, Eurobank.
  3. Formation: approximately 10 days to incorporate, estimated cost $2K plus annual compliance of $3K
  4. Timeline: 120 days visa processing + 10 days formation = approximately 130 days to be fully operational
  5. Visa pathway: Golden Visa - Zone A (Athens / Thessaloniki / Islands) (minimum investment $872K, 60-month initial permit)
Industry Key Facts
Main challenge; only EUR 100M/yr pharma R&D
Trial Bureaucracy
New Ministerial Decision standardizes trial contracts
2026 Reform
AbbVie and Bayer established Athens trial hubs
Notable Entrants
Full centralized approval as EU member
EMA Access
Compare Greece vs Top Alternatives for Biotech / Life Sciences
🇬🇷Greece
61
🇪🇪Estonia
68

Biotech / Life Sciences industry scores

🇬🇷Greece
61
🇸🇬Singapore
73

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Greece good for Biotech / Life Sciences in 2026?

Greece ranks #11 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 61/100. The top strengths for Biotech / Life Sciences founders are funding access and family viability. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Greece?

Greece applies a statutory corporate tax rate of 22%, and an IP box regime at 10% for qualifying IP income. The jurisdiction has 57 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Greece have Biotech / Life Sciences-specific programs or incentives?

Full EMA centralized approval pathway as EU member. Clinical trial activity historically limited by bureaucracy - Greece attracts roughly EUR 100M in pharma R&D annually. January 2026 Ministerial Decision standardized trial contracts and fixed internal deadlines. AbbVie and Bayer have established Athens clinical trial operations. Greece offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Greece compare to other jurisdictions for Biotech / Life Sciences?

Greece ranks #11 for Biotech / Life Sciences with 61/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by personal tax, where Greece is weaker. Use NomadSignal's comparison pages to evaluate Greece head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.